Avacopan and prednisone taper were associated with similar and substantial improvements in the control of active disease in multiple organ systems in the phase 3 ADVOCATE trial. Patients with ANCA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback